A PYMNTS Company

Switzerland: Bioethanol development finally underway after $2.5B acquisition

By  |  April 30, 2013

After several years of restructuring, Switzerland-based Clariant is looking to develop its second-generation bioethanol technology – which uses crops to create biofuel – as a direct result of its $2.5 billion buyout of Sued-Chemie. The company, purchased in 2011, focuses on catalyst making and has reportedly allowed for Clariant to utilize more advanced technology and research. The company has now announced new testing of that technology in efforts to strengthen its stance against rivals Royal DSM NV and Novosymes A/S. Testing is reportedly going on in Munich, Germany. The company is also planning to sell three of its commodity-chemical units for $1.3 billion to re-invest profits into the project. Clariant says the deals will be finalized by the end of this September.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Bloomberg

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.